Showing 321-340 of 644 for: Cochrane Systematic Reviews > Respiratory 
- Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy
Cochrane Systematic Reviews, 20-Jan-2003
Following pelvic radiotherapy (RT), a proportion of women experience problems related to sexual function, which are multifactorial in origin. The physical components relate to distortion of the perineum and vagina, which may occur as a result of surgery a
- Interventions for tobacco use prevention in Indigenous youth
Cochrane Systematic Reviews, 30-Nov-2021
- Interventions for treating functional dysphonia in adults
Cochrane Systematic Reviews, 6-Nov-2008
Poor voice quality due to functional dysphonia can lead to a reduced quality of life. In occupations where voice use is substantial it can lead to a loss of employment.
- Interventions for treating genital chlamydia trachomatis infection in pregnancy
Cochrane Systematic Reviews, 26-Oct-1998
Chlamydia trachomatis is a sexually transmitted infection. Mother-to-child transmission can occur at the time of birth and may result in ophthalmia neonatorum or pneumonitis in the newborn.
- Interventions for treating melioidosis
Cochrane Systematic Reviews, 21-Oct-2002
Melioidosis is an infectious disease that occurs in tropical regions, particularly in Thailand. It is caused by the bacterium Burkholderia pseudomallei and is a serious condition which can be fatal. Beta-lactam antibiotics have dramatically reduced the ri
- Interventions for treating tuberculous pericarditis
Cochrane Systematic Reviews, 10-Sep-2017
Tuberculous pericarditis can impair the heart's function and cause death; long term, it can cause the membrane to fibrose and constrict causing heart failure. In addition to antituberculous chemotherapy, treatments include corticosteroids, drainage, and s
- Interventions to improve antibiotic prescribing practices in ambulatory care
Cochrane Systematic Reviews, 19-Oct-2005
The development of resistance to antibiotics by many important human pathogens has been linked to exposure to antibiotics over time. The misuse of antibiotics for viral infections (for which they are of no value) and the excessive use of broad spectrum an
- Interventions to increase influenza vaccination rates of those 60 years and older in the community
Cochrane Systematic Reviews, 30-May-2018
The effectiveness of interventions to increase influenza vaccination uptake in people aged 60 years and older varies by country and participant characteristics. This review updates versions published in 2010 and 2014.
- Intra‐amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newborns
Cochrane Systematic Reviews, 20-Jan-2010
Early surfactant reduces mortality and pulmonary complications in preterm infants with respiratory distress syndrome. However, current surfactant administration strategies require endotracheal intubation with or without continued mechanical ventilation. B
- Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis
Cochrane Systematic Reviews, 21-Jul-2003
Allergic rhinitis and asthma are mediated by similar allergic mechanisms. They may represent two manifestations of the same united airway disease and therefore intranasal corticosteroids (INCS) could improve asthma. Nevertheless none of the asthma guideli
- Intranasal steroids for acute sinusitis
Cochrane Systematic Reviews, 2-Dec-2013
Acute sinusitis is a common reason for primary care visits. It causes significant symptoms and often results in time off work and school.
- Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema
Cochrane Systematic Reviews, 30-Oct-2019
Pleural infection, including parapneumonic effusions and thoracic empyema, may complicate lower respiratory tract infections. Standard treatment of these collections in adults involves antibiotic therapy, effective drainage of infected fluid and surgical
- Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndrome
Cochrane Systematic Reviews, 11-May-2011
Clara cell secretory protein (CCSP) is an immune-modulating and anti-inflammatory agent. CCSP is available synthetically as recombinant human Clara cell protein (rhCC10). It has been shown in animal models to reduce lung injury, improve pulmonary complian
- Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease
Cochrane Systematic Reviews, 20-Sep-2016
Alpha-1 antitrypsin deficiency is an inherited disorder that can cause chronic obstructive pulmonary disease (COPD). People who smoke are more seriously affected and have a greater risk of dying from the disease. Therefore, the primary treatment is to hel
- Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
Cochrane Systematic Reviews, 20-Apr-2005
Since the advent of inhaled ß2 -agonists, anticholinergic agents and glucocorticoids, the role of aminophylline in paediatric acute asthma has become less clear. There remains some consensus that it is beneficial in children with acute severe asthma, rece
- Intravenous beta2‐agonists for acute asthma in the emergency department
Cochrane Systematic Reviews, 22-Jan-2001
Inhaled beta-agonist therapy is central to the management of acute asthma. The use of intravenous beta-agonist agents may also be beneficial in this setting.
- Intravenous beta2-agonists versus intravenous aminophylline for acute asthma
Cochrane Systematic Reviews, 13-Nov-2012
Inhaled beta2-agonist therapy is central to the management of acute asthma. For rapid bronchodilation in severe cases, penetration of inhaled drug to the affected small conducting airway may be impeded, and the intravenous (IV) rather than inhaled adminis
- Intravenous dexamethasone for extubation of newborn infants
Cochrane Systematic Reviews, 23-Oct-2001
Endotracheal tubes are foreign bodies that may injure the upper airway causing laryngeal edema. This in turn may result in failure of extubation in preterm infants. Corticosteroids have been used prophylactically to reduce upper airway obstruction and fac
- Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis
Cochrane Systematic Reviews, 31-Jan-2013
Wegener's granulomatosis (WG) is a necrotizing small-vessel vasculitis that can affect any organ in the body but mainly affects the upper and lower respiratory tract, the kidneys, joints, skin and eyes. The current mainstay of remission induction therapy
- Intravenous versus inhalation anaesthesia for one-lung ventilation
Cochrane Systematic Reviews, 14-Feb-2017
This is an update of a Cochrane Review first published in The Cochrane Library, Issue 2, 2008.
